In November 2020, Pfizer claimed its Covid-19 shot was 95 per cent effective against Covid-19, but this was highly misleading and based on flawed methodology. One trick used to get this misleadingly high efficacy figure is to ignore people who got Covid-19 within 14 days after their first shot.

In Pfizer’s trial, 37.2 per cent of those who were tested for Covid-19 within 13 days of their first shot were positive – but not counted as such. How can this skew results? As explained on Substack’s “Where are the numbers,” a newsletter about the abuse of science and statistics:

“Imagine the most extreme case in which every vaccinated person gets covid within the first two weeks of their first dose. Then, assuming (as is likely) that none get infected a second time within the 19 weeks, according to the study definition no vaccinated people ever got covid over the whole period of the study.

“If only one person in the unvaccinated comparative cohort had got Covid, over the same period, the vaccine efficacy (defined as one minus the proportion of vaccinated infected divided by the proportion of unvaccinated infected times 100) will be reported as 100 per cent.”

The study found that during any two-week period from December 28, 2020, to May 19, 2021, the Covid-19 infection rate was about 0.8 per cent, compared to 37.2 per cent among those tested within two weeks of their first shot.

“If people were tested every two weeks then we could reasonably conclude the vaccinated were getting infected – within two weeks of their first jab – at a rate that was almost 50 times greater than the general rate for this population,” but “if you don’t look for covid, by not testing for it, or by ignoring the test results you won’t find it.”

They also pointed out that no deaths occurred among the participants who tested positive for Covid-19 and had at least one Covid-19-like symptom, including among the 812 (out of 1,482) who were unvaccinated.

But since this clearly makes the shots look unnecessary and ineffective, it was conveniently ignored: “[T]here was a grand total of zero deaths: an infection fatality rate (IFR) of 0 per cent. And 812 of those were unvaccinated. Bear in mind that this when Covid was supposed to have been rampaging globally and causing widespread death.

“And of course, that nugget somehow never got mentioned in the abstract, mains results, conclusions, or discussion. It only appeared in the detailed results section (along with the fact that only 2 per cent were hospitalized).”

Former Blackrock portfolio manager Edward Dowd also warned about problems with Pfizer’s trial. A friend from the biotech industry told him that the all-cause mortality endpoint had been missed by Pfizer in the original clinical trial, meaning that in the jab group there were more deaths than in the placebo group.

Normally, during the drug approval process, if you fail that endpoint, you do not get approved. Dowd said, “When that came out in November, the biotech executives who saw that decided they weren’t going to get boosters, and the people who weren’t vaxxed were not going to get vaxxed.”

Whistleblower Brooke Jackson, a regional director formerly employed by Pfizer subcontractor Ventavia Research Group, which was testing Pfizer’s Covid-19 vaccine, also witnessed falsified data, unblinded patients, inadequately trained vaccinators and lack of proper follow-up on adverse events that were reported.

“I was working on Pfizer’s trial,” she said in the film Anecdotals. “What I saw was like nothing I’ve ever seen before.”

She explained, “The speed in which they were enrolling in the study – four to five coordinators pushing through 40, 50, 60 patients a day. We were not storing the vaccine at its appropriate temperature, the failures in reporting serious adverse events. We had so many reports of adverse events … we just could not keep up. The study doctor signed a physical exam when he wasn’t even in clinic.

“Then Ventavia had unblinded every patient that was randomised in the trial. When we brought it to their attention, that’s what we were instructed to do – remove the evidence and destroy it. Emails about mislabelled blood specimens per Pfizer’s protocol, we should have immediately stopped enrolling, but they never told Pfizer.

“I would bring the concerns to my managers and it was, “We’re understaffed.” The FDA – they only see what Pfizer gives them. So, I was documenting all of this. And on the 25th of September, I went directly to the FDA, and about six and a half hours later, I lost my job. I was fired.”

The FDA and Pfizer attempted to hide the Covid-19 shot clinical trial data for 75 years, but the FDA was ordered by the US District Court for the Northern District of Texas to release redacted versions of trial documents on a much faster schedule.

As part of the court order, 80,000 pages of documents related to the FDA’s approval of Pfizer’s Covid-19 shots were released June 1, 2022.

Among those documents were case report forms revealing that deaths and severe adverse events took place during Phase three trials, but, as reported by Children’s Health Defense, Pfizer had “a trend of classifying almost all adverse events – and in particular severe adverse events – as being ‘not related’ to the vaccine.”

Pfizer has profited immensely nonetheless, earning a record $100 billion in 2022, including $37.8 billion for its Covid-19 shots and $18.9 billion for its antiviral drug Paxlovid.

• The Defender report